Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
J Nutr Health Aging ; 20(10): 1010-1023, 2016.
Article in English | MEDLINE | ID: mdl-27925141

ABSTRACT

OBJECTIVE: To determine the effects of feeding traditional and renal protective foods (RPF) supplemented with functional food bioactives on glomerular filtration rate (GFR), lean body percent (LB%), and selected circulating biomarker and metabolite concentrations in a geriatric dog model. DESIGN: Randomized block design and cross-sectional study. SETTING: Hill's Pet Nutrition, Inc. dog colony. PARTICIPANTS: Eighty-one geriatric dogs (mean age, 10.4; range, 7.9-14.2 years) and 30 mature-adult dogs (mean age, 5.0; range, 3.3-6.9 years). INTERVENTION: Geriatric dogs were fed one of three foods (n = 27 per group) for 6 months: a traditional RPF (control) that was energy dense and mildly protein-restricted, or control food supplemented with increasing amounts of functional food bioactives: fish oil, lipoic acid, fruits and vegetables, and higher quality protein sources [functional foods one (FF1) and two (FF2)]. Geriatric dogs were compared before and after the feeding trial with mature adult dogs. MEASUREMENTS: Renal function was assessed by GFR, LB% was determined by dual energy x-ray absorptiometry, and circulating biomarkers and metabolites were measured in blood. RESULTS: Before the feeding trial, GFR (+28.2%), LB% (+18.6%), and serum total protein (+10.0%) were higher in mature versus healthy geriatric dogs (all P<0.001). Geriatric dogs consuming all three foods increased (P<0.001) GFR over time; group averages ranged from 13.0-16.9%. Dogs fed the highest supplemented level of bioactives (FF2) had lower (P<0.001) symmetric dimethylarginine (SDMA) concentrations (-14.3%). Feeding functional foods did not alter body weight, but increased (P<0.001) serum protein concentration (+6.7%). CONCLUSION: Supplementation with functional food bioactives can temporarily reverse the age-associated decline in renal function and serum total protein.


Subject(s)
Aging/blood , Geriatric Assessment , Kidney/physiology , Absorptiometry, Photon , Aged , Animals , Arginine/analogs & derivatives , Arginine/blood , Biomarkers/blood , Body Weight , Carnitine/blood , Cross-Sectional Studies , Diet/veterinary , Dietary Proteins/administration & dosage , Dietary Proteins/blood , Dietary Supplements , Disease Models, Animal , Dogs , Female , Fish Oils/administration & dosage , Fish Oils/blood , Fruit , Glomerular Filtration Rate , Humans , Kidney/physiopathology , Male , Thioctic Acid/administration & dosage , Thioctic Acid/blood , Vegetables
2.
Neuroscience ; 202: 87-98, 2012 Jan 27.
Article in English | MEDLINE | ID: mdl-22166344

ABSTRACT

Dietary polyphenols exert neuroprotective effects in ischemic injury. The protective effects of a procyanidin type A trimer (trimer 1) isolated from a water soluble cinnamon extract (CE) were investigated on key features of ischemic injury, including cell swelling, increased free radical production, increased intracellular calcium ([Ca(2+)](i)), mitochondrial dysfunction, and the reduction in glutamate uptake. Astrocyte (glial) swelling is a major component of cytotoxic brain edema in ischemia and, along with vasogenic edema, may contribute to increased intracranial pressure, brain herniation, and additional ischemic injuries. C6 glial cultures were exposed to oxygen-glucose deprivation (OGD) for 5 h, and cell swelling was determined at 90 min after the end of OGD. OGD-induced increases in glial swelling were significantly blocked by trimer 1, but not by the major nonpolyphenol fractions of CE including cinnamaldehyde and coumarin. Increased free radical production, a contributing factor in cell swelling following ischemic injury, was also significantly reduced by trimer 1. Mitochondrial dysfunction, another key feature of ischemic injury, is hypothesized to contribute to glial swelling. Depolarization of the inner mitochondrial membrane potential (ΔΨ(m)) was assessed using a fluorescent dye (tetramethylrhodamine ethyl ester [TMRE]), and was significantly attenuated by trimer 1 as was OGD-induced increased [Ca(2+)](i). Taken together with our previous observation that blockers of [Ca(2+)](i) reduce cell swelling, our results indicate that trimer 1 may attenuate cell swelling by regulating [Ca(2+)](i). Trimer 1 also significantly attenuated the OGD-induced decrease in glutamate uptake. In addition, cyclosporin A, a blocker of the mitochondrial permeability pore (mPT), but not FK506 (that does not block the mPT), reduced the OGD-induced decline in glutamate uptake indicating a role of the mPT in such effects. Thus, the effects of trimer 1 in attenuating the reduction in glutamate uptake are likely mediated through their action on the mitochondria.


Subject(s)
Biflavonoids/pharmacology , Brain Ischemia/pathology , Catechin/pharmacology , Cinnamomum zeylanicum/chemistry , Glutamic Acid/metabolism , Neuroglia/drug effects , Proanthocyanidins/pharmacology , Adenosine Triphosphate/metabolism , Biflavonoids/isolation & purification , Calcium/metabolism , Catechin/isolation & purification , Cell Size/drug effects , Cells, Cultured , Cyclosporine/pharmacology , Glucose/deficiency , Glutamate-Ammonia Ligase/metabolism , Humans , Hypoxia/pathology , Membrane Potentials/drug effects , Mitochondrial Membranes/drug effects , Plant Extracts/pharmacology , Proanthocyanidins/isolation & purification , Reactive Nitrogen Species/metabolism , Reactive Oxygen Species/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL